Viewing Study NCT01423760

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:05 AM
Ignite Modification Date: 2026-01-07 @ 7:14 AM
Study NCT ID: NCT01423760
Status: TERMINATED
Last Update Posted: 2016-10-06
First Post: 2011-08-23
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Common Safety Follow-up Trial of Tecemotide (L-BLP25)
Sponsor: Merck KGaA, Darmstadt, Germany
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-Small Cell Lung Cancer View
None Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Vaccine View
None Stimuvax View
None Tecemotide View
None L-BLP25 View
None Non-Small Cell Lung Carcinoma View
None Multiple Myeloma View